Sana Biotechnology : JPMorgan Starts Sana Biotechnology at Neutral With $35

0
13


MT Newswires 2021

All news about SANA BIOTECHNOLOGY, INC.

Sales 2020

Net income 2020 -235 M

Net cash 2020 18,8 M

P/E ratio 2020 -18,5x
Yield 2020
Capitalization 5 948 M
5 948 M
EV / Sales 2020
EV / Sales 2021
Nbr of Employees 240
Free-Float 87,9%

Chart SANA BIOTECHNOLOGY, INC.

Duration :


Period :

Sana Biotechnology, Inc. Technical Analysis Chart | MarketScreener

Technical analysis trends SANA BIOTECHNOLOGY, INC.

Short Term Mid-Term Long Term
Trends Neutral Neutral Neutral

Income Statement Evolution



Read More: Sana Biotechnology : JPMorgan Starts Sana Biotechnology at Neutral With $35

Leave a reply